Lemonade, Inc. LMND
43.39 USD +2.05 (+4.96%)
Nov 4, 2026, 9:32 AM EST
42.48 Day range 43.12
39.60 52-week range 99.90
- YTD
- -39.04%
- 1 year
- -26.03%
Analyst view
Consensus: hold
Hold
Price target (mean) 58.44 +34.7% upside
Now 43.39
- Target (low)
- 38.00
- Target (mean)
- 58.44
- Target (high)
- 92.00
Ratings (0m) 11 3 buy · 6 hold · 2 sell
- Strong buy1
- Buy2
- Hold6
- Sell2
- Strong sell0
Recommendation trend
- This month 11
- 1 month ago 11
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.57818 | -0.63 – -0.41 | -0.51 | -13.4% | 322.48M | +65.8% | 11 |
| Next quarter | -0.236 | -0.30 – -0.19 | -0.29 | +18.6% | 340.39M | +49.2% | 10 |
| Current year | -1.85 | -1.94 – -1.73 | -2.24 | +17.4% | 1.22B | +65.0% | 12 |
| Next year | -1.10 | -1.75 – -0.69 | -1.85 | +40.7% | 1.64B | +34.9% | 12 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 6, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Aug 19, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jul 30, 2026 | Piper Sandler | Maintained | Neutral | Neutral |
| Jul 30, 2026 | Keefe, Bruyette & Woods | Upgrade | Underperform | Market Perform |
| Jul 15, 2026 | Piper Sandler | Maintained | Neutral | Neutral |
| Jul 8, 2026 | Keefe, Bruyette & Woods | Maintained | Underperform | Underperform |
| Jul 8, 2026 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| May 21, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Apr 30, 2026 | Piper Sandler | Maintained | Neutral | Neutral |
| Apr 30, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Apr 30, 2026 | Truist Securities | Maintained | Buy | Buy |
| Mar 17, 2026 | Morgan Stanley | Upgrade | Equal-Weight | Overweight |
| Feb 24, 2026 | Keefe, Bruyette & Woods | Maintained | Underperform | Underperform |
| Jan 14, 2026 | Cantor Fitzgerald | Maintained | Overweight | Overweight |
| Jan 6, 2026 | Truist Securities | Initiated | — | Buy |
| Nov 25, 2025 | Keefe, Bruyette & Woods | Maintained | Underperform | Underperform |
| Nov 24, 2025 | Citizens | Maintained | Market Outperform | Market Outperform |
| Nov 17, 2025 | Morgan Stanley | Maintained | Underweight | Underweight |
| Nov 10, 2025 | Morgan Stanley | Maintained | Underweight | Underweight |
| Oct 10, 2025 | Piper Sandler | Maintained | Neutral | Neutral |
| Oct 7, 2025 | Morgan Stanley | Maintained | Underweight | Underweight |
| Sep 17, 2025 | Piper Sandler | Maintained | Neutral | Neutral |
| Aug 18, 2025 | BMO Capital | Maintained | Underperform | Underperform |
| Jul 14, 2025 | Morgan Stanley | Maintained | Underweight | Underweight |
| Jul 2, 2025 | BMO Capital | Maintained | Underperform | Underperform |
| Jul 1, 2025 | Keefe, Bruyette & Woods | Reiterated | Underperform | Underperform |
| Apr 22, 2025 | Keefe, Bruyette & Woods | Maintained | Underperform | Underperform |
| Apr 8, 2025 | Morgan Stanley | Downgrade | Equal-Weight | Underweight |
| Feb 26, 2025 | Citizens Capital Markets | Reiterated | Market Outperform | Market Outperform |
| Feb 26, 2025 | Piper Sandler | Maintained | Neutral | Neutral |
